NEWAMSTERDAM PHARMA CO NV
NAMSNASDAQ🏆 #1431 by market capEarnings Nov 3 · PreUS Equity
$27.59▼ $0.03 (−0.11%)
Live1h▲ 0.0%
24h▼ 0.1%
7d▲ 0.7%
14d▼ 1.1%
30d▼ 17.1%
1y▲ 10.3%
🏦Market Cap
$3.23B
Small Cap
📈Revenue Growth (YoY)
-88.9%
Declining
📊Gross Margin
—
💵FCF Margin
1648.5%
Strong
⚖️P/S Ratio
469.7x
Expensive
Otter Score
65
Fair
Earnings
Q3 · 2026Reported 2026-08-05Earnings Per Share
Actual
-0.52
Expected
-0.48
miss
−7.90%
YoY −246.70%
Revenue
Actual
$3.70M
Expected
$2.83M
beat
+30.70%
YoY −83.50%
Consensus estimates
Recent quarters
Q3 2026
-0.52
miss
Q2 2026
-0.40
beat
Q1 2026
-0.63
miss
Q4 2025
-0.41
miss